Skip to main content Back to Top
Advertisement

9/11/2019

Rabies Immune Globulin

Products Affected - Description

    • Imogam Rabies-HT solution for injection, Sanofi Pasteur, 150 units/mL, 10 mL vial, NDC 49281-0190-10
    • Imogam Rabies-HT solution for injection, Sanofi Pasteur, 150 units/mL, 2 mL vial, NDC 49281-0190-20

Reason for the Shortage

    • Sanofi Pasteur has Imogam Rabies-HT on shortage due to manufacturing delays.

Available Products

    • HyperRAB solution for injection, Grifols, 300 units/mL, 1 mL vial, NDC 13533-0318-10
    • HyperRAB solution for injection, Grifols, 300 units/mL, 1 mL vial, NDC 13533-0318-01
    • HyperRAB solution for injection, Grifols, 300 units/mL, 5 mL vial, NDC 13533-0318-05
    • HyperRAB solution for injection, Grifols, 300 units/mL, 5 mL vial, NDC 13533-0318-50
    • HyperRAB S-D solution for injection, Grifols, 150 units/mL, 10 mL vial, NDC 13533-0618-10
    • HyperRAB S-D solution for injection, Grifols, 150 units/mL, 10 mL vial, NDC 13533-0618-11
    • HyperRAB S-D solution for injection, Grifols, 150 units/mL, 2 mL vial, NDC 13533-0618-02
    • HyperRAB S-D solution for injection, Grifols, 150 units/mL, 3 mL vial, NDC 13533-0618-20
    • KEDRAB solution for injection, Kedrion Biopharma, Inc., 150 units/mL, 10 mL vial, NDC 76125-0150-10
    • KEDRAB solution for injection, Kedrion Biopharma, Inc., 150 units/mL, 2 mL vial, NDC 76125-0150-02

Estimated Resupply Dates

    • Sanofi Pasteur has Imogam Rabies-HT available with ordering restrictions. Access post-exposure information via link on the VACCINESHOPPE home page found at https://www.vaccineshoppe.com/.

Updated

Created September 11, 2019 by Rachael Freeman, PharmD, BCPS. © 2019, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins